05545806 is referenced by 1070 patents and cites 8 patents.

The invention relates to transgenic non-human animals capable of producing heterologous antibodies and transgenic non-human animals having inactivated endogenous immunoglobulin genes. In one aspect of the invention, endogenous immunoglobulin genes are suppressed by antisense polynucleotides and/or by antiserum directed against endogenous immunoglobulins. Heterologous antibodies are encoded by immunoglobulin genes not normally found in the genome of that species of non-human animal. In one aspect of the invention, one or more transgenes containing sequences of unrearranged heterologous human immunoglobulin heavy chains are introduced into a non-human animal thereby forming a transgenic animal capable of functionally rearranging transgenic immunoglobulin sequences and producing a repertoire of antibodies of various isotypes encoded by human immunoglobulin genes. Such heterologous human antibodies are produced in B-cells which are thereafter immortalized, e.g., by fusing with an immortalizing cell line such as a myeloma or by manipulating such B-cells by other techniques to perpetuate a cell line capable of producing a monoclonal heterologous antibody. The invention also relates to heavy and light chain immunoglobulin transgenes for making such transgenic non-human animals as well as methods and vectors for disrupting endogenous immunoglobulin loci in the transgenic animal.

Title
Ransgenic non-human animals for producing heterologous antibodies
Application Number
574748
Publication Number
5545806
Application Date
December 16, 1992
Publication Date
August 13, 1996
Inventor
Robert M Kay
San Francisco
CA, US
Nils Lonberg
San Francisco
CA, US
Agent
Townsend & Townsend & Crew
Assignee
GenPharm International
CA, US
IPC
A61K 39/00
C07H 21/64
C12N 15/00
View Original Source